Journal profile · Pharmacology & Pharmacy
Naunyn-Schmiedeberg s Archives of Pharmacology
ISSN 0028-1298 · eISSN 1432-1912 · Springer Berlin Heidelberg · GERMANY · Monthly · Founded 1873
Naunyn-Schmiedeberg s Archives of Pharmacology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.88; hybrid open access; APC about USD 4,790; median 74 days to acceptance (165 articles, last 24 months); community-reported acceptance: fairly easy; 1,172 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Naunyn-Schmiedeberg s Archives of Pharmacology is published by Springer Berlin Heidelberg and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research and Ion channel regulation and function, together about 31.1% of its articles. Its main subfields are Cellular and Molecular Neuroscience. (generated from OpenAlex topic counts and CAS ranking data)
Naunyn-Schmiedeberg's Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT). The journal publishes reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg's Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Roland SeifertPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named Germany 44, United States 8, Australia 3, Netherlands 3, Poland 3 (75 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology12.2%
- Neuroscience and Neuropharmacology ResearchNeuroscience10.5%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology8.4%
- Biomedical and Chemical ResearchMedicine8.1%
- Neuropeptides and Animal PhysiologyNeuroscience6.8%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience6%
- Nitric Oxide and Endothelin EffectsMedicine5.3%
- Cardiac electrophysiology and arrhythmiasMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.88LetPub ·
- Impact factor (publisher) 2025
- 4Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.8Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- SJR 2026-06
- 0.88LetPub ·
- SNIP 2026-06
- 1.02LetPub ·
- h-index
- 83LetPub ·
- h-index
- 166OpenAlex ·
- i10-index
- 10,525OpenAlex ·
- 2-year mean citedness
- 3.52OpenAlex ·
- Self-citation rate
- 7.5%LetPub ·
- Share of gold OA articles
- 22.91%LetPub ·
Volume
- Articles per year
- 1,122LetPub ·
- Downloads per year (publisher) 2025
- 2,200,000Publisher website ·
Articles by year OpenAlex count · 25,553 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,020 | 268 | 429 |
| 2025 | 1,172 | 323 | 4,092 |
| 2024 | 802 | 213 | 6,004 |
| 2023 | 540 | 157 | 6,373 |
| 2022 | 183 | 68 | 3,032 |
| 2021 | 154 | 57 | 2,457 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
74 daysMedian, submission to acceptance · P25–P75 48 days – 117 days
- Acceptance to online
- median 14 days (165 articles)
- Submission to online
- median 93 days
- Sample
- 165 articles with submission and acceptance dates (2,445 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 3,790 / GBP 2,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 350 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,000 words
- Reference style
- Author–date
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted3, with length limits
- brief reportThis is a suitable format for preliminary or limited results of original research, including negative data. Abstract (max. 200 words) structured as Introduction…main text ≤ 200 words · figures and tables ≤ 4
- editorialThe Editor-in-Chief assigns each manuscript to one of the editors or to a guest editor. The editor selects the referees, corresponds with the authors and makes …Length not stated
- reviewWhile systematic reviews and scoping reviews are preferred, other forms of review (e.g., narrative) may be considered. Abstract (max. 350 words) structured as I…main text ≤ 350 words · figures and tables ≤ 4
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Plagiarism, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship Policy
Authorship should incorporate and should be restricted to those who have contributed substantially to the work in one or more of the following categories: • Conceived of or designed study • Performed research • Analyzed data • Contributed new methods or models • Wrote the paper All submissions are checked via the plagiarism detection software iThenticate. Submissions suspected of any kind of plagi…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Naunyn-Schmiedeberg's Archives of Pharmacology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Plagiarism All submissions are checked via the plagiarism detection software iThenticate.
Submissions suspected of any kind of plagiarism will be rejected immediately without further peer-review.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- GERMANY
- Language
- English
- Frequency
- Monthly
- Founded
- 1873
- ISSN
- 0028-1298
- Electronic ISSN
- 1432-1912
- Society / sponsor
- German Society of Experimental and Clinical Pharmacology and Toxicology
- Latest issue on the website
- Volume 399, Issue 11 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Naunyn-Schmiedeberg s Archives of Pharmacology
What CAS zone is Naunyn-Schmiedeberg s Archives of Pharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Naunyn-Schmiedeberg s Archives of Pharmacology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Naunyn-Schmiedeberg s Archives of Pharmacology?
The latest impact factor listed by LetPub is 3.88; CiteScore 4.9, h-index 166.
How long does peer review take at Naunyn-Schmiedeberg s Archives of Pharmacology?
Based on the dates recorded on 165 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 74 days (interquartile range 48–117 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Naunyn-Schmiedeberg s Archives of Pharmacology?
According to the journal's author guidelines: Abstract: ≤ 350 words; Keywords: ≥ 4; Manuscript length: ≤ 3,000 words; Reference style: Author–date; Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Naunyn-Schmiedeberg s Archives of Pharmacology based?
Of the 75 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are Germany (44), United States (8) and Australia (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Naunyn-Schmiedeberg s Archives of Pharmacology?
According to LetPub and DOAJ records, Naunyn-Schmiedeberg s Archives of Pharmacology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Naunyn-Schmiedeberg s Archives of Pharmacology open access, and what is the APC?
Naunyn-Schmiedeberg s Archives of Pharmacology is a hybrid journal. For open-access publication: APC about USD 4,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .